Literature DB >> 32527514

From policy to practice: Pilot program increases access to medication for opioid use disorder in rural Colorado.

Tanya R Sorrell1, Mary Weber1, Andrea Alvarez2, Nancy Beste3, Ursula Hollins4, Claudia R Amura1, Paul F Cook5.   

Abstract

Medication for opioid use disorder (MOUD) is an important approach to address the opioid crisis, but rural areas have limited access to MOUD. In 2016, Nurse Practitioners (NPs) and Physician Assistants (PAs) became eligible to prescribe buprenorphine. Local and state stakeholders in Colorado, including clinicians, policymakers, law enforcement, and patient advocates, formed a collaborative to develop legislative policy and programs for the opioid epidemic. A pilot MOUD program was developed in 2017 to increase the number of NPs and PAs providing MOUD and to increase access to MOUD in 2 counties with high opioid overdose rates. A central coordinating site selected 3 clinical agencies through an open call for proposals, with review of applications by nursing faculty experts and a community advisory board. We then monitored the number of waivered providers and patients served in targeted counties. Providers at pilot program sites tracked costs, community-level barriers, facilitators of success via monthly reports. Sites were funded for 18 months. Seven MOUD providers were added in County 1, a 350% increase compared to the prior year, and there are now 8 MOUD providers in County 2 where there were previously none. County 1 increased MOUD services from 99 clients in 2017 to 582 in 2018 and 317 during the first half of 2019. County 2 provided MOUD services for 60 new clients in 2018 and 46 in the first half of 2019. Cognitive-behavioral therapy, family therapy, and other approaches were used to increase patient engagement and days without opioid use. Successes included community outreach, referral networks, and provider education to reduce stigma. Barriers to sustainability included 1) reimbursement, 2) stigma, and 3) coordination with hospitals. Policy efforts, legislation, and academic-community collaboration led to an increase in MOUD providers and patients served in rural counties severely affected by the opioid crisis.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Medication-assisted treatment; Nurse practitioner; Opioid; Physician assistant; Policy; Rural

Year:  2020        PMID: 32527514      PMCID: PMC7292886          DOI: 10.1016/j.jsat.2020.108027

Source DB:  PubMed          Journal:  J Subst Abuse Treat        ISSN: 0740-5472


  14 in total

1.  Self-reported health status and mortality in a multiethnic US cohort.

Authors:  D L McGee; Y Liao; G Cao; R S Cooper
Journal:  Am J Epidemiol       Date:  1999-01-01       Impact factor: 4.897

2.  Screening, Brief Intervention, and Referral to Treatment: Nurses Helping Colorado Training Program.

Authors:  Paul F Cook; Laurra Aagaard; Fara Bowler; Laura Rosenthal; Lisa Krug Avery; Mary Weber
Journal:  J Nurs Educ       Date:  2018-08-01       Impact factor: 1.726

3.  The PHQ-9: validity of a brief depression severity measure.

Authors:  K Kroenke; R L Spitzer; J B Williams
Journal:  J Gen Intern Med       Date:  2001-09       Impact factor: 5.128

4.  A brief measure for assessing generalized anxiety disorder: the GAD-7.

Authors:  Robert L Spitzer; Kurt Kroenke; Janet B W Williams; Bernd Löwe
Journal:  Arch Intern Med       Date:  2006-05-22

5.  Addressing childhood obesity in low-income, ethnically diverse families: outcomes and peer effects of MEND 7-13 when delivered at scale in US communities.

Authors:  Paul M Sacher; Maria Kolotourou; Stavros Poupakis; Paul Chadwick; Duncan Radley; Jamie Fagg
Journal:  Int J Obes (Lond)       Date:  2018-08-03       Impact factor: 5.095

6.  The Physician Clinical Support System-Buprenorphine (PCSS-B): a novel project to expand/improve buprenorphine treatment.

Authors:  James E Egan; Paul Casadonte; Tracy Gartenmann; Judith Martin; Elinore F McCance-Katz; Julie Netherland; John A Renner; Linda Weiss; Andrew J Saxon; David A Fiellin
Journal:  J Gen Intern Med       Date:  2010-05-11       Impact factor: 5.128

7.  The Fifth Edition of the Addiction Severity Index.

Authors:  A T McLellan; H Kushner; D Metzger; R Peters; I Smith; G Grissom; H Pettinati; M Argeriou
Journal:  J Subst Abuse Treat       Date:  1992

8.  Office-Based Opioid Treatment with Buprenorphine (OBOT-B): Statewide Implementation of the Massachusetts Collaborative Care Model in Community Health Centers.

Authors:  Colleen T LaBelle; Steve Choongheon Han; Alexis Bergeron; Jeffrey H Samet
Journal:  J Subst Abuse Treat       Date:  2015-06-26

9.  Screening, Brief Intervention, and Referral to Treatment in a rural Ryan White Part C HIV clinic.

Authors:  Lucy J Graham; Amy L Davis; Paul F Cook; Mary Weber
Journal:  AIDS Care       Date:  2015-11-07

10.  Overcoming Barriers to Prescribing Buprenorphine for the Treatment of Opioid Use Disorder: Recommendations from Rural Physicians.

Authors:  C Holly A Andrilla; Tessa E Moore; Davis G Patterson
Journal:  J Rural Health       Date:  2018-10-19       Impact factor: 4.333

View more
  2 in total

Review 1.  Implications of Increased Access to Buprenorphine for Medical Providers in Rural Areas: A Review of the Literature and Future Directions.

Authors:  Hannah M Gregory; Veronica M Hill; Robert W Parker
Journal:  Cureus       Date:  2021-11-24

2.  Outcomes from the medication assisted treatment pilot program for adults with opioid use disorders in rural Colorado.

Authors:  Claudia R Amura; Tanya R Sorrell; Mary Weber; Andrea Alvarez; Nancy Beste; Ursula Hollins; Paul F Cook
Journal:  Subst Abuse Treat Prev Policy       Date:  2022-01-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.